David Saunders Selected Research

Phacoemulsification

4/2004

Orbital cellulitis after phacoemulsification and intraocular lens implantation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David Saunders Research Topics

Disease

13	Malaria 01/2023 - 12/2010
6	Infections 01/2024 - 12/2005
4	Falciparum Malaria (Plasmodium falciparum Malaria) 03/2023 - 12/2010
4	Human Influenza (Influenza) 01/2019 - 01/2013
2	COVID-19 12/2023 - 12/2022
2	Vivax Malaria 12/2014 - 01/2014
2	Body Weight (Weight, Body) 12/2014 - 11/2012
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 10/2022
1	Reinfection 09/2022
1	Opioid-Related Disorders (Opiate Addiction) 01/2021
1	Wounds and Injuries (Trauma) 01/2021
1	Calculi (Calculus) 01/2021
1	Communicable Diseases (Infectious Diseases) 01/2020
1	Western Equine Encephalomyelitis (Encephalitis, Western Equine) 01/2020
1	Acoustic Neuroma (Acoustic Neurinoma) 04/2019
1	Glucosephosphate Dehydrogenase Deficiency 10/2018
1	Cerebral Malaria 01/2018
1	Psychotic Disorders (Schizoaffective Disorder) 08/2016
1	Mental Disorders (Mental Disorder) 08/2016
1	Astrocytoma (Pilocytic Astrocytoma) 08/2016
1	Seizures (Absence Seizure) 08/2016
1	Cholangiocarcinoma 11/2015
1	Neoplasms (Cancer) 11/2015
1	Pathologic Constriction (Stenosis) 11/2015
1	Pancreatic Neoplasms (Pancreatic Cancer) 11/2015
1	Klatskin Tumor 11/2015
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2014
1	AIDS-Related Complex (ARC) 06/2013
1	Parasitemia 11/2012
1	Neutropenia 12/2010
1	Chickenpox 02/2009
1	Traumatic Brain Injuries (Traumatic Brain Injury) 07/2006
1	Cardiotoxicity 01/2006
1	Sepsis (Septicemia) 12/2005
1	Orbital Cellulitis 04/2004

Drug/Important Bio-Agent (IBA)

7	VaccinesIBA 01/2024 - 01/2013
6	ArtesunateIBA 09/2022 - 12/2010
5	Antimalarials (Antimalarial Agents)IBA 03/2023 - 12/2010
5	artenimol (dihydroartemisinin)IBA 09/2022 - 01/2014
5	piperaquineIBA 09/2022 - 01/2014
4	Primaquine FDA Link 01/2022 - 01/2014
3	Antiviral Agents (Antivirals)IBA 01/2019 - 01/2014
3	artemisinin (artemisinine)IBA 06/2013 - 01/2011
1	Malaria VaccinesIBA 01/2023
1	N-(2-cyanoethylene)urea (BA 1)IBA 12/2022
1	Messenger RNA (mRNA)IBA 12/2022
1	N-methyl-valyl-amiclenomycin (BA 2)IBA 12/2022
1	Merozoite Surface Protein 1 (MSA1)IBA 09/2022
1	proguanil drug combination atovaquone (malarone)FDA Link 09/2022
1	Mefloquine (Lariam)FDA LinkGeneric 09/2022
1	Opioid Analgesics (Opioids)IBA 01/2021
1	Investigational DrugsIBA 01/2020
1	Inactivated VaccinesIBA 01/2020
1	GadoliniumIBA 04/2019
1	Zanamivir (Relenza)FDA Link 01/2019
1	Oseltamivir (Tamiflu)FDA Link 01/2019
1	Matrix Metalloproteinases (MMPs)IBA 10/2018
1	Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA 10/2018
1	Codon (Codons)IBA 01/2018
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2016
1	BilirubinIBA 11/2015
1	Alanine Transaminase (SGPT)IBA 11/2015
1	EnzymesIBA 11/2015
1	Alkaline PhosphataseIBA 11/2015
1	Chloroquine (Aralen)FDA LinkGeneric 12/2014
1	Neuraminidase (Sialidase)IBA 01/2014
1	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2013
1	DNA (Deoxyribonucleic Acid)IBA 01/2013
1	mirincamycinIBA 12/2011
1	Viral DNAIBA 02/2009
1	Protons (Proton)IBA 07/2006
1	Ropivacaine (Naropin)FDA LinkGeneric 01/2006
1	Levobupivacaine (Chirocaine)FDA Link 01/2006
1	Bupivacaine (Bupivacaine Hydrochloride)FDA LinkGeneric 01/2006
1	Mitochondrial DNA (mtDNA)IBA 12/2005

Therapy/Procedure

5	Therapeutics 09/2022 - 03/2016
2	Chemoprevention 10/2014 - 01/2014
1	Combined Modality Therapy 10/2022
1	Limb Salvage 01/2021
1	Surgical Amputation (Amputations) 01/2021
1	AP protocol 1 09/2019
1	Complementary Therapies (Alternative Medicine) 01/2017
1	Drug Therapy (Chemotherapy) 08/2016
1	Intraocular Lens Implantation 04/2004
1	Phacoemulsification 04/2004